GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 44th Annual J.P. Morgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback